The human cytomegalovirus UL18 gene product is a homolog of cellular m
ajor histocompatibility (MHC) class I antigens. UL18 has been proposed
to protect virus-infected cells against natural killer (NK) cell cyto
toxicity by engaging NK cell killer inhibitory receptors (KIR) for MHC
class I. UL18 binds to a novel immunoglobulin superfamily glycoprotei
n, designated Leukocyte Immunoglobulin-like Receptor (LIR-1). This pro
tein is distinct from, but related to, known KIRs and binds cellular M
HC class I antigens. The cytoplasmic domain of LIR-1 contains four put
ative immunoreceptor tyrosine-based inhibitory motifs. Upon tyrosine p
hosphorylation, LIR-1 associates with the tyrosine phosphatase SHP-1.
In contrast to KIRs, LIR-1 is expressed predominantly on monocytic and
B lymphoid cell types, suggesting a distinct biological function.